Hydrocodone GF Interactions
There are 658 drugs known to interact with Hydrocodone GF (chlorpheniramine / hydrocodone), along with 20 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 217 are major, 437 are moderate, and 4 are minor.
- View all 658 medications that may interact with Hydrocodone GF
- View Hydrocodone GF alcohol/food interactions (2)
- View Hydrocodone GF disease interactions (20)
Most frequently checked interactions
View interaction reports for Hydrocodone GF (chlorpheniramine / hydrocodone) and the medicines listed below.
- alprazolam
- amlodipine
- aspirin
- atorvastatin
- baclofen
- bupropion
- citalopram
- clonazepam
- cyclobenzaprine
- Cymbalta (duloxetine)
- furosemide
- gabapentin
- hydrochlorothiazide
- hydrocodone
- ibuprofen
- levothyroxine
- lisinopril
- losartan
- Lyrica (pregabalin)
- meloxicam
- metformin
- omeprazole
- pantoprazole
- prednisone
- simvastatin
- tramadol
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- zolpidem
Hydrocodone GF alcohol/food interactions
There are 2 alcohol/food interactions with Hydrocodone GF (chlorpheniramine / hydrocodone).
Hydrocodone GF disease interactions
There are 20 disease interactions with Hydrocodone GF (chlorpheniramine / hydrocodone) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
Report options
More about Hydrocodone GF (chlorpheniramine / hydrocodone)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.